These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 27158444)
1. Adrenocorticotropic hormone gel in the treatment of systemic lupus erythematosus: A retrospective study of patients. Li X; Golubovsky J; Hui-Yuen J; Shah U; Olech E; Lomeo R; Singh V; Busch H; Strandberg MJ; Strandberg K; Horowitz L; Askanase A F1000Res; 2015; 4():1103. PubMed ID: 27158444 [TBL] [Abstract][Full Text] [Related]
2. Acthar gel in the treatment of nephrotic syndrome: a multicenter retrospective case series. Madan A; Mijovic-Das S; Stankovic A; Teehan G; Milward AS; Khastgir A BMC Nephrol; 2016 Mar; 17():37. PubMed ID: 27036111 [TBL] [Abstract][Full Text] [Related]
3. Cost-Effectiveness of Acthar Gel Versus Standard of Care for the Treatment of Exacerbations in Moderate-to-Severe Systemic Lupus Erythematosus. Bindra J; Chopra I; Hayes K; Niewoehner J; Panaccio M; Wan GJ Adv Ther; 2023 Jan; 40(1):194-210. PubMed ID: 36266383 [TBL] [Abstract][Full Text] [Related]
4. Immunomodulatory effects of H.P. Acthar Gel on B cell development in the NZB/W F1 mouse model of systemic lupus erythematosus. Decker DA; Grant C; Oh L; Becker PM; Young D; Jordan S Lupus; 2014 Jul; 23(8):802-12. PubMed ID: 24759631 [TBL] [Abstract][Full Text] [Related]
5. Patient-Reported Outcomes from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Repository Corticotropin Injection (Acthar Askanase AD; Wan GJ; Panaccio MP; Zhao E; Zhu J; Bilyk R; Furie RA Rheumatol Ther; 2021 Mar; 8(1):573-584. PubMed ID: 33687687 [TBL] [Abstract][Full Text] [Related]
6. Safety and Efficacy of Belimumab to Treat Systemic Lupus Erythematosus in Academic Clinical Practices. Hui-Yuen JS; Reddy A; Taylor J; Li X; Eichenfield AH; Bermudez LM; Starr AJ; Imundo LF; Buyon J; Furie RA; Kamen DL; Manzi S; Petri M; Ramsey-Goldman R; van Vollenhoven RF; Wallace DJ; Askanase A J Rheumatol; 2015 Dec; 42(12):2288-95. PubMed ID: 26523030 [TBL] [Abstract][Full Text] [Related]
7. A retrospective pilot study examining the use of Acthar gel in sarcoidosis patients. Baughman RP; Barney JB; O'Hare L; Lower EE Respir Med; 2016 Jan; 110():66-72. PubMed ID: 26626451 [TBL] [Abstract][Full Text] [Related]
8. Treatment of moderately to severely active systemic lupus erythematosus with adrenocorticotropic hormone: a single-site, open-label trial. Fiechtner JJ; Montroy T Lupus; 2014 Aug; 23(9):905-12. PubMed ID: 24795067 [TBL] [Abstract][Full Text] [Related]
9. Corticosteroid Use and Adherence in Patients Treated with Acthar Gel for Advanced Sarcoidosis. Hayes K; Niewoehner J; Rice JB; Downes N; Hagopian E; Ma I; Wan GJ Adv Ther; 2023 Nov; 40(11):4999-5015. PubMed ID: 37728695 [TBL] [Abstract][Full Text] [Related]
11. Post Hoc Biomarker Analyses from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Repository Corticotropin Injection (Acthar® Gel) for Persistently Active Systemic Lupus Erythematosus. Askanase AD; Wright D; Zhao E; Zhu J; Bilyk R; Furie RA Rheumatol Ther; 2021 Dec; 8(4):1871-1886. PubMed ID: 34478124 [TBL] [Abstract][Full Text] [Related]
12. A Narrative Review of Repository Corticotropin Injection for the Treatment of Systemic Lupus Erythematosus. Askanase AD; Furie RA Adv Ther; 2022 Jul; 39(7):3088-3103. PubMed ID: 35641860 [TBL] [Abstract][Full Text] [Related]
13. H.P. Acthar Gel (repository corticotropin injection) treatment of patients with multiple sclerosis and diabetes. Kutz C Ther Adv Chronic Dis; 2016 Jul; 7(4):190-7. PubMed ID: 27433309 [TBL] [Abstract][Full Text] [Related]
14. Clinical and Economic Evaluation of Repository Corticotropin Injection: A Narrative Literature Review of Treatment Efficacy and Healthcare Resource Utilization for Seven Key Indications. Philbin M; Niewoehner J; Wan GJ Adv Ther; 2017 Aug; 34(8):1775-1790. PubMed ID: 28660550 [TBL] [Abstract][Full Text] [Related]
15. Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index-50 enhances the ability of SLE Responder Index to identify responders in clinical trials. Touma Z; Gladman DD; Ibañez D; Taghavi-Zadeh S; Urowitz MB J Rheumatol; 2011 Nov; 38(11):2395-9. PubMed ID: 21885488 [TBL] [Abstract][Full Text] [Related]
16. Adrenocorticotropic hormone analog use for podocytopathies. Filippone EJ; Dopson SJ; Rivers DM; Monk RD; Udani SM; Jafari G; Huang SC; Melhem A; Assioun B; Schmitz PG Int Med Case Rep J; 2016; 9():125-33. PubMed ID: 27418857 [TBL] [Abstract][Full Text] [Related]